Image (Rizatriptan 01)
Chemical structure of Rizatriptan Benzoate, showing its molecular arrangement including indole and benzoate components.*
Rizatriptan Benzoate Tablet
Product Images NDC 69097-866
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 69097-866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Rizatriptan 02)
A line graph depicting the estimated probability of response over time (hours post-dose) for Rizatriptan Benzoate tablets at 5 mg and 10 mg doses compared to placebo. The graph shows response percentages increasing from 0 to 2 hours after dosing, with higher doses associated with greater response rates.*
Image (Rizatriptan 03)
A line graph depicting the estimated probability of remediation or rescue over 24 hours post-dose for placebo and Rizatriptan Benzoate Tablets 5 mg and 10 mg. The y-axis shows the probability percentage, while the x-axis shows hours post-dose, illustrating higher probabilities with Rizatriptan compared to placebo.*
Image (Rizatriptan 04)
A line graph comparing the percent response over time (hours post stage 2 dose) between Rizatriptan Benzoate orally disintegrating tablets and placebo. The graph shows data points with 95% confidence intervals for both treatments from 0.5 to 2 hours after dose, indicating increasing response percentages over time for both groups.*
Image (Rizatriptan Benzoate 10mg Blister Foil)
Label sheet for Rizatriptan Benzoate Tablet, USP 10 mg by Cipla USA Inc. The label includes the NDC 69097-866-17, warnings to keep out of reach of children, lot number, expiration date placeholders, and barcodes. The label repeats six identical sections for packaging use.*
Image (Rizatriptan Benzoate 10mg Carton)
Box packaging label for Rizatriptan Benzoate Tablets, USP, 10 mg oral tablets by Cipla USA Inc. The label shows the product name prominently with dosage strength 10 mg, indicating 18 unit-dose tablets in three blister cards of six tablets each. The label includes the NDC number 69097-866-85, pharmacist dispensing information, barcode, and manufacturer details.*
Image (Rizatriptan Benzoate 5mg Blister Foil)
Label for Rizatriptan Benzoate Tablet, USP 5 mg strength. The label includes the NDC number 69097-865-17, warnings to keep out of reach of children, manufacturer information as Cipla USA Inc., Warren, NJ, and placeholders for lot and expiration dates. The label is repeated six times in a grid arrangement with barcodes.*
Image (Rizatriptan Benzoate 5mg Carton)
Packaging label for Rizatriptan Benzoate Tablets, USP, 5 mg by Cipla USA Inc. The label indicates the product is prescription-only and includes 18 unit-dose tablets, arranged as 3 blister cards of 6 tablets each. The label features dosage strength prominently and includes a barcode and QR code for product identification.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
